TIDMYGEN
RNS Number : 7152A
Yourgene Health PLC
27 September 2022
Yourgene Health plc
("Yourgene" or the "Company")
AGM statement
Manchester, UK - 27 September 2022: Yourgene (AIM: YGEN), the
international molecular diagnostics group, will be holding its
Annual General Meeting ("AGM") at 2:00pm today.
At the meeting, Dr John Brown CBE, Non-executive Chairman, will
make the following statement:
'It is a pleasure to be at my first AGM as Chairman of Yourgene
after 3 years on the Board as a Non-executive Director. I would
like to thank my predecessor Adam Reynolds for his contribution to
making Yourgene the exciting business it is today. The business is
a growing force in genomic testing and is addressing growth
opportunities in non-invasive prenatal testing, oncology,
reproductive health and infectious disease, with an increasing
presence in key overseas geographies including North America,
Europe and Asia.
We continue to see the core business performing at pre-pandemic
growth levels.
The team has done a great job during the pandemic and, having
come out the other side, is now both better resourced and equipped.
With solid progress being made in the first half, we are now
focused on a number of pipeline opportunities that will support
growth in the second half and underpin next year's performance. The
Board looks forward to updating the market at the time of our
interim results release in due course.
Yourgene is distinguished by its breadth of high growth value
propositions, some of which represent near-term commercial
opportunities to build market share, while others reflect truly
accretive prospects to create longer-term value, including through
geographic expansion and new product or service launches.
I look forward to working with the Board, shareholders, and the
management team to chart our way to delivering the best mix of
these near and long term opportunities.'
After the formal AGM proceedings, Lyn Rees, CEO, will provide
shareholders with a short business update ahead of the onsite
Investor Open Day later in the afternoon. The Open Day is to be
held at the Company's new headquarters in Skelton House, Manchester
Science Park, M15 6SH. This is now the sole UK business premise for
Yourgene and all other locations including Citylabs have moved to
the new site.
The AGM will be available as a hybrid event via the Investor
Meet Company platform. Investors can sign up to Investor Meet
Company for free and register for the Yourgene Health meeting via:
https://www.investormeetcompany.com/yourgene-health-plc/register-investor
.
The presentation recording and responses to investor questions
will be made available on the Investor Meet Company platform at the
earliest opportunity.
Yourgene Health plc Tel: +44 (0)161 669 8122
Lyn Rees, Chief Executive Officer investors@yourgene-health.com
Barry Hextall, Chief Financial Officer
Joanne Cross, Director of Marketing
Cairn Financial Advisers LLP (NOMAD) Tel: +44 (0)20 7213 0880
Liam Murray / James Caithie / Ludovico
Lazzaretti
Singer Capital Markets (Corporate Tel: +44 (0)20 7496 3000
Broker)
Aubrey Powell / Tom Salvesen / George
Tzimas
Walbrook PR Ltd (Media and Investor Tel: +44 (0)20 7933 8780 or yourgene@walbrookpr.com
Relations)
Paul McManus / Lianne Applegarth Mob: 07980 541 893 / Mob: 07584
Alice Woodings 391 303 /
Mob: 07407 804 654
About Yourgene Health plc
Yourgene Health is an international molecular diagnostics group
which develops integrated genomic technologies and services
enabling precision medicine. The group works in partnership with
global leaders in DNA technology to advance diagnostic science.
Yourgene primarily develops, manufactures, and commercialises
simple and accurate molecular diagnostic solutions, for
reproductive health, precision medicine and now infectious
diseases. The Group's flagship products include non-invasive
prenatal tests (NIPT) for Down's Syndrome and other genetic
disorders, Cystic Fibrosis screening tests, invasive rapid
aneuploidy tests, and a recent extension into the oncology space
with DPYD genotyping.
The Yourgene Genomic Services team works with healthcare
professionals, researchers and pharmaceutical organisations to
support and accelerate scientific advances in genomic medicine. The
division's specialist services guide decisions about abnormalities,
hereditary risk and treatment in addition to providing novel
insights in research and discovery. Accredited clinical services
are provided in Oncology and Reproductive Health within the UK and
worldwide. The team of scientific experts offer consultative
services to help guide partners in selecting the right technology
and approach for their applications.
In August 2020, Yourgene acquired Coastal Genomics, Inc., a
sample preparation technology company based in Vancouver, Canada,
enabling the Company to extend its offering and IP portfolio in the
DNA sample preparation sector. The acquisition increased Yourgene's
geographical penetration into the US and Canada, supplementing
existing coverage in the UK, Europe, MEA and Asia.
Yourgene Health is headquartered in Manchester, UK with offices
in Taipei, Singapore, the US and Canada, and is listed on the
London Stock Exchange's AIM market under the ticker "YGEN". For
more information visit www.yourgene-health.com and follow us on
twitter @Yourgene_Health.
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
AGMBKABBKBKBACB
(END) Dow Jones Newswires
September 27, 2022 02:01 ET (06:01 GMT)
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yourgene Health (LSE:YGEN)
Historical Stock Chart
From Apr 2023 to Apr 2024
